Accelerated Growth
Acrobot
The Acrobot Company Limited develops precision surgical systems for minimally invasive, bone conserving, orthopaedic surgery. The company has developed an ‘active constraint’ robot to assist surgeons during surgical procedures that allows for smaller incision during knee replacement procedures as well as a ‘passive constraint’ surgical navigation device for hip resurfacing operations.
View website
Cell Medica
Cell Medica is a cell therapy company working on new techniques to cure human diseases based upon a treatment method called cellular immunotherapy. This technique involves harnessing and enhancing the power of the human immune system to fight disease.
View website
Ceres Power
Ceres Power is a high growth product development company founded in 2001 to commercially exploit revolutionary fuel cell technology originally developed within Imperial College during the preceding 10 years. The company combines significant industrial experience involving the commercialisation of high technology with world class research and development expertise.
View website
Circassia
Circassia Holdings Limited is a clinical-stage specialty biopharmaceutical company focused on developing medicines designed to control immune system responses. The Company's initial focus is on the development and commercialisation of a range of allergy therapeutics, based on its proprietary technology, which have the potential to transform current treatment.
View website
Cortexica
View website
deltaDOT
deltaDOT is a Life Science company that is developing and commercialising innovative technologies for the separation and analysis of biomolecules. The company is focused on harnessing the cutting edge technologies developed at Imperial College and their application to biomolecular separation and analysis. deltaDOT has a strong patent portfolio and extensive in-house expertise in instrumentation, automation, microfluidics, and data analysis.
View website
EMcision
EMcision™ is a medical device company that uses established technologies in innovative ways to produce and market medical devices that provide customers with clinically relevant and cost effective medical devices that enhance the quality of life.
View website
Evince Technology
Evince Technology has created a new class of diamond electronic device that will revolutionise the control of electrical power. For the first time the energy industry will have the prospect of controlling utility 15,000V voltages using single electronic devices, enabling the creation of cost effective, direct grid-linked solid-state power control systems for the first time.
View website
EVO Electric
Evo Electric is developing high power density, axial flux electric motors based on a unique modular design. The company is targetting the hybrid bus and electric vehicle markets.
View website
IXICO
IXICO is a leading provider of Imaging Solutions to the pharmaceutical and medical devices industries.IXICO's goal is to accelerate product development bringing patients earlier access to safe and effective treatments; increase sensitivity to precisely quantify treatment effects and therefore enable better decision making throughout the drug development pipeline; and reduce costs through use of smaller cohorts and shorter trial duration.
View website
Microsaic Systems
Microsaic develops next generation systems capable of identifying trace compounds such as pharmaceuticals, explosives, chemical weapons, and narcotics. Mass spectrometers are sophisticated systems used in everything from explosives detection to drug discovery. Today's mass spectrometers are large, heavy and expensive. Microsaic's breakthrough Ionchip technology integrates the system onto a single silicon chip leading to massive size, cost and reliability advantages.
View website
Midaz Lasers
Midaz manufactures an innovative range of diode-pumped solid state (DPSS) lasers based on proprietary technology, providing a breakthrough in laser performance. Midaz technology offers an unparalleled combination of increased efficiency, ultra-compact size and competitive pricing, whilst simultaneously offering high power, almost perfect beam quality and high peak power pulsed operation. Applications are diverse, but Midaz products will be particularly beneficial in industrial processes where speed and the highest quality are desirable, for example, in manufacturing of electronic components and other semiconductor devices.
View website
Molecular Vision
Molecular Vision is an Imperial College spin-out company that develops low-cost diagnostic devices for use in the doctor's surgery and in the home. Its proprietary devices combine microfluidic chips with organic-semiconductor light-sources and photodetectors to provide lab-quality diagnostic tests in a miniaturised, easy-to-use, disposable format.
View website
Mycologix
Mycologix is focused on the development of low cost, highly efficient biological pre-treatment process for 2nd generation biofuels. The company was formed in 2009 based on more than 20 years of research by Dr. Richard Murphy of the Deptartment of Biological Sciences at Imperial College London. Mycologix has secured grant support from TSB and the Carbon Trust Incubator programme. Mycologix is being developed by Nick Brooks, previously an Entrepreneur-in-Residence. Nick spent 30 years at Shell in a variety of senior management positions. Since leaving Shell in 2005, Nick has been CEO of several Biofuels businesses, including Sun Biofuelds, Bioverda Europe, and BioEnergy Africa.
Myotec Therapeutics
Myotec Therapeutics is focused on the development of novel treatments in the field of the muscle and fat wasting syndrome, cachexia. Myotec is developing a pipeline of small molecule therapeutics, of which its most advanced investigational product is expected to enter Phase II clinical studies during 2010.
View website
Navion Pharma
Navion is a new therapeutics company focusing on discoveries in the areas of Cancer and Metastatic disease (secondary cancer). Navion’s science is based on the research of Professor Mustafa Djamgoz, an expert in Cancer Biology and a specialist in Biophysics and Bioelectricity at Imperial College London.
Nexeon
Nexeon is a battery materials and licensing company with a unique silicon anode technology. Nexeon's technology unlocks the potential of silicon to deliver increased capacity without compromising lithium-ion battery cycle life, providing lighter batteries with more power and longer lifetime between charges.
View website
Novacem
Novacem has developed a carbon negative cement which offers a transformative solution to the challenge of reducing carbon emissions from the cement industry. Novacem's cement is based on a non-carbonate raw material, magnesium silicate, and uses a relatively low temperature production process. Overall, production absorbs more CO2 than it emits. For every tonne of Ordinary Portland Cement replaced by Novacem, CO2 emissions will be reduced by up to 900kg
View website
OSspray
OSspray is an emerging specialty dental company seeking to develop and commercialise bioactive glass materials for air polishing and air abrasion applications. US regulatory approval for the Company’s first product has been received and a CE Mark applied, enabling both US and European launches to occur in 2008. Clinical data generated in the US and UK demonstrates significant benefits compared to incumbent products including improved cleaning, whitening and desensitisation.
View website
Plaxica
Plaxica is developing a new generation of polymers derived from sustainable resources. Plaxica’s polymers are a range of polylactic acid (PLA) based materials which have improved physical properties compared with first generation biopolymers, a smaller environmental footprint, are fully recyclable and cost competitive with current oil-based alternatives. These second generation PLA polymers are aimed at the replacement of conventional oil-derived products like PET, polypropylene and polystyrene.
View website
Polytherics
PolyTherics is a company dedicated to using biomedical polymers to optimise pharmaceuticals, in particular biopharmaceuticals, for the treatment and cure of the world's most important diseases. PolyTherics' most advanced programmes are designed to exploit TheraPEG ™ technology, an innovative, patent protected approach to the PEGylation of therapeutic proteins and antibody fragments. Through the targeted attachment of PEG via naturally occurring disulfide bonds within proteins, biochemical and biophysical properties can be altered without compromising biological activity.
View website
PSE
PSE is a world-leading provider of Advanced Process Modelling (APM) technology and Model-Based Innovation (MBI) services to the process industries. The company operates from headquarters in London, with offices in key markets of the USA, Japan, Korea and Central Europe, and agency operations in China and India.
View website
QuantaSol
Quantasol is developing high efficiency compound semiconductors cells for use in concentrator photovolatiac systems. QuantaSol’s technology is expected to deliver not only greater conversion efficiency, but also better spectral performance and longer cell lifetimes than competing technologies.
View website
RepRegen
RepRegen's goal is to create smart materials that help the body repair itself. The company's first target is bone repair and plans extend to the repair of any tissue. Materials based on glass with components that make it more bone-like have been implanted in patients since the 1970s.
View website
RespiVert
RespiVert is a small molecule drug discovery company working towards the identification of new treatments for patients with Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis (CF) and severe asthma. The more severe forms of these diseases are poorly responsive to existing therapies such as inhaled corticosteroids and new disease modifying treatments are urgently required.
View website
Smart Surgical Appliances
Smart Surgical Appliances (SSA) is a catalyst for the development of surgical appliances, generating revenue through licensing its products to medical device manufacturers. Surgical appliances include any disposable or re-usable instruments used during the treatment of patients undergoing surgery, ranging from the simple surgical swab to more complex operative tools.
STS
Southside Thermal Sciences (STS) Ltd. was founded in 2002 as spin out from Imperial College London to develop and commercialise sensors based on optical technology. The company’s Intellectual Property is the result of over 5 years of research by a team of leading scientist at Imperial College. The STS team combines proven business skills and decades of industry and entrepreneurial experience with the scientific excellence of the technology’s inventors.
View website
Veryan Medical
Veryan Medical is developing innovative solutions for vascular disease using the principles of biomimicry. Biomimicry (from bios, meaning life, and mimesis, meaning to imitate) involves studying nature’s best ideas and imitating these designs and processes to solve human problems. The company is using its advanced understanding of the physics of blood flow to develop a range of cutting edge vascular products to address vascular disease in areas with strong unmet vascular needs. This is the BioMimics 3D™ solution.
View website
